A major breakthrough in pancreatic cancer treatment is giving new hope to patients and doctors around the world. A new experimental drug called daraxonrasib is able to nearly double the survival time ...

In cancer care, every hour a patient spends getting treatment is an hour away from the rest of their life. It could mean another afternoon in an infusion chair instead of at home. Another childcare ...

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within ...

Add Yahoo as a preferred source to see more of our stories on Google. Moderna expects that thousands of melanoma patients could benefit from the new vaccine within the first few years of approval. - ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its potential to improve treatment outcomes. The designation is based on phase 1 ...